The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Dobrokhotova Iu.É.

Kafedra akusherstva i ginekologii Moskovskogo fakul'teta Rossiĭskogo gosudarstvennogo meditsinskogo universiteta

Dzhokhadze L.S.

Kafedra akusherstva i ginekologii lechebnogo fakul'teta Rossiĭskogo gosudarstvennogo meditsinskogo universiteta

Preconception care as a real way to improve the perinatal outcomes

Authors:

Dobrokhotova Iu.É., Dzhokhadze L.S.

More about the authors

Journal: Russian Journal of Human Reproduction. 2019;25(6): 38‑43

Read: 6956 times


To cite this article:

Dobrokhotova IuÉ, Dzhokhadze LS. Preconception care as a real way to improve the perinatal outcomes. Russian Journal of Human Reproduction. 2019;25(6):38‑43. (In Russ.)
https://doi.org/10.17116/repro20192506138

Recommended articles:
Immu­nological aspe­cts of reccurent pregnancy loss. Russian Journal of Human Reproduction. 2024;(5):64-71
Functional cyto­kine redu­ndancy in pregnancy. Russian Journal of Human Reproduction. 2024;(6):73-80
Psoriasis in pregnant women. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(5):517-524
Sexual function of women during pregnancy. Russian Bulletin of Obstetrician-Gynecologist. 2024;(6):112-117

References:

  1. WHO. Meeting to develop a global consensus on preconception care to reduce maternal and childhood mortality and morbidity. World Health Organization Headquarters, Geneva, 6—7 February 2012: meeting report. Accessed November 08, 2019. Available from: http://www.who.int/maternal_child_adolescent/documents/concensus_preconception_care/en/ [Meeting to develop a global consensus on preconception care to reduce maternal and childhood mortality and morbidity. Geneva: World Health Organization, 2013. Accessed November 08, 2019. (In Russ.). Available at:] http://apps. who.int/iris/handle/10665/78067
  2. De Franco EA, Ehrlich S, Muglia LJ. Influence of interpregnancy interval on birth timing. BJOG: British Journal of Obstetrics and Gynaecology. 2014;121(13):1633-1640.
  3. De Franco EA, Seske LM, Greenberg JM, Muglia LJ. Influence of interpregnancy interval on neonatal morbidity. American Journal of Obstetrics and Gynecology. 2015;212(3):386.e1-386.e9. https://doi.org/10.1016/j.ajog.2014.11.017
  4. Family planning: a global handbook for providers. Geneva, WHO; 2016. Accessed November 08, 2019. Available at: https://www.fphandbook.org
  5. Larsen B, Hwang J. Mycoplasma, Ureaplasma, and Adverse Pregnancy Outcomes: A Fresh Look. Infectious Diseases in Obstetrics and Gynecology. 2010;2010:521921. https://doi.org/10.1155/2010/521921
  6. CDC. General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR: Morbidity and Mortality Weekly Report. Recommendations and Reports. 2011;60(2):26. Accessed November 08, 2019. Available at: https://www.cdc.gov/MMWR/Preview/MMWRhtml/rr6002a1.htm
  7. Federal’naya sluzhba gosudarstvennoj statistiki. Rosstat. Vyborochnoe nablyudenie reproduktivnyh planov naseleniya v 2017 godu. Tablica 21 «Srednij vozrast materi pri rozhdenii detej v raznye gody 2015—2017 gg.» Accessed November 08, 2019. (In Russ.). Available at: https://www.gks.ru/free_doc/new_site/RPN17/reports.html
  8. Rogers LM, Cordero AM, Pfeiffer CM, Hausman DB, Tsang BL, De-Regil LM, Rosenthal J, Razzaghi H, Wong EC, Weakland AP, Bailey LB. Global folate status in women of reproductive age: a systematic review with emphasis on methodological issues. Annals of the New York Academy of Sciences. 2018;1431(1):35-57. https://doi.org/10.1111/nyas.13963
  9. VOZ. Otsenka folatnogo statusa u razlichnyh grupp naseleniya po kontsentratsii folata v syvorotke krovi i krasnykh krovyanykh kletkakh. Informatsionnaya sistema dannykh o soderzhanii vitaminov i mineralov v produktakh pitaniya. Zheneva (VOZ), 2012. Accessed November 08, 2019. (In Russ.). Available at: http://www.who.int/iris/bitstream/10665/75584/4/WHO_NMH_NHD_EPG_12.1_rus pdf
  10. Daly LE, Kirke PN, Molloy A, Weir DG, Scott JM. Folate levels and neural tube defects. Implications for prevention. JAMA. 1995;274(21):1698-1702.
  11. Czeizel AE, Dobó M, Vargha P. Hungarian cohort-controlled trial of periconceptional multivitamin supplementation shows a reduction in certain congenital abnormalities. Birth Defects Research. Part A. Clinical and Molecular Teratology. 2004;70(11):853-861.
  12. Goh YI, Bollano E, Einarson TR, Koren G. Prenatal multivitamin supplementation and rates of congenital anomalies: a metaanalysis. Journal of Obstetrics and Gynaecology. 2006;28(8):680-689.
  13. Surén P, Roth C, Bresnahan M, Haugen M, Hornig M, Hirtz D, Lie KK, Lipkin WI, Magnus P, Reichborn-Kjennerud T, Schjølberg S, Davey Smith G, Øyen AS, Susser E, Stoltenberg C. Association between maternal use of folic acid supplements and risk of autism spectrum disorders in children. JAMA. 2013;309(6):570-577. https://doi.org/10.1001/jama.2012.155925
  14. Reijnders IF, Mulders AGMGJ, van der Windt M, Steegers EAP, Steegers-Theunissen RPM. The impact of periconceptional maternal lifestyle on clinical features and biomarkers of placental development and function: a systematic review. Human Reproduction Update. 2019;25(1):72-94. https://doi.org/10.1093/humupd/dmy037
  15. Figo Working Group on Best Practice in Maternal-Fetal Medicine; International Federation of Gynecology and Obstetrics. International Journal of Gynecology and Obstetrics. 2015;128(1):80-82.
  16. European Surveillance of Congenital Anomalies (EUROCAT) Special Report: Prevention of Neural Tube Defects by Periconceptional Folic Acid Supplementation in Europe. Part IIa — Country Specific Chapters (Austria to Ireland) and IIb — Country Specific Chapters (Italy to UK). 2009. Accessed October 30, 2019. Available at: https://www.researchgate.net/publication/291430176_Prevention_of_Neural_Tube_Defects_by_Periconceptional_Folic_Acid_Supplementation_in_Europe_Eurocat_Special_Report_May_2003
  17. Scaglione F, Panzavolta G. Folate, folic acid and 5-methyltetrahydrofolate are not the same thing. Xenobiotica. 2014;44(5):480-488. https://doi.org/10.3109/00498254.2013.845705
  18. Peng Y, Dong B, Wang Z. Serum folate concentrations and all-cause, cardiovascular disease and cancer mortality: A cohort study based on 1999-2010 National Health and Nutrition Examination Survey (NHANES). International Journal of Cardiology. 2016;219:136-142. https://doi.org/10.1016/j.ijcard.2016.06.024
  19. Zhou X, Meng Y. Association between serum folate level and cervical cancer: a meta-analysis. Archives of Gynecology and Obstetrics. 2016;293(4):871-877. https://doi.org/10.1007/s00404-015-3852-5
  20. Pietrzik K, Bailey L, Shane B. Folic acid and L-5-methyltetrahydrofolate: comparison of clinical pharmacokinetics and pharmacodynamics. Clinical Pharmacokinetics. 2010;49(8):535-548. https://doi.org/10.2165/11532990-000000000-00000
  21. Tam C, O’Connor D, Koren G. Circulating unmetabolized folic acid: relationship to folate status and effect of supplementation. Obstetrics and Gynecology International. 2012;2012:485179. https://doi.org/10.1155/2012/485179
  22. Micle O, Muresan M, Antal L, Bodog F, Bodog A. The influence of homocysteine and oxidative stress on pregnancy outcome. Journal of Medicine and Life. 2012;5(1):68-73.
  23. Dobrohotova YuE, Suhih GT, Fajzullin LZ, Ochan TB, Jobava EM. The role of hyperhomocysteinemia in the Genesis of undeveloped pregnancy and miscarriage. Russkiy meditsinskiy zhurnal. 2010;13(17):1110-1112. (In Russ.)
  24. Dzhilandze NM, Ivanova LA. The use of dietary supplements by University students. Olymplus. Gumanitarnaya versiya. 2015;1:5-9. (In Russ.)
  25. Osterhues A, Holzgreve W, Michels KB. Shall we put the world on folate? Lancet. 2009;374(9694):959-961.
  26. Von Stenglin A, Buchwald S, Bannemerschult R. Awareness and periconceptional use of folic acid — results of a European study in women of childbearing age (abstract and oral presentation). The European Journal of Contraception and Reproductive Health Care. 2010; 15(s1):37-38 (abstract and oral presentation).
  27. Bart S, Marr J, Diefenbach K, Trummer D, Sampson-Landers C. Folate status and homocysteine levels during a 24-week oral administration of a folate-containing oral contraceptive: a randomized, double-blind, active-controlled, parallel-group, US-based multicenter study. Contraception. 2012;85(1):42-50. https://doi.org/10.1016/j.contraception.2011
  28. Cronin M, Schellschmidt I, Dinger J. Rate of pregnancy after using drospirenone and other progestin-containing oral contraceptives. Obstetrics and Gynecology. 2009;114(3):616-622. https://doi.org/10.1097/AOG.0b013e3181b46f54
  29. Crider KS, Yang TP, Berry RJ, Bailey LB. Folate and DNA methylation: a review of molecular mechanisms and the evidence for folate’s role. Advances in Nutrition. 2012;3(1):21-38. https://doi.org/10.3945/an.111.000992

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.